Advertisement
Advertisement
TLSI
TriSalus Life Sciences, Inc. Common Stock
4.43
USDSponsored
-0.03
-0.67%
May 08, 16:00 UTC -4
Closed
Pre-Market
4.51
+0.08
+1.90%
TLSI Earnings Reports
Positive Surprise Ratio
TLSI beat 3 of 9 last estimates.
33%
Next Report
Tomorrow AMC
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.65M
/-$0.15
Implied change from Q4 25 (Revenue/ EPS)
-19.36%
/-28.57%
Implied change from Q1 25 (Revenue/ EPS)
+16.17%
/-61.54%
TriSalus Life Sciences, Inc. Common Stock earnings per share and revenue
On Jan 12, 2026, TLSI reported earnings of -0.21 USD per share (EPS) for Q4 25, missing the estimate of -0.13 USD, resulting in a -56.37% surprise. Revenue reached 13.21 million, compared to an expected 12.94 million, with a 2.08% difference. The market reacted with a +1.21% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -0.15 USD, with revenue projected to reach 10.65 million USD, implying an decrease of -28.57% EPS, and decrease of -19.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were TriSalus Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, TriSalus Life Sciences, Inc. Common Stock reported EPS of -$0.21, missing estimates by -56.37%, and revenue of $13.21M, 2.08% above expectations.
How did the market react to TriSalus Life Sciences, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 1.21%, changed from $5.80 before the earnings release to $5.87 the day after.
When is TriSalus Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for TriSalus Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, TriSalus Life Sciences, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $10.65M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement